[1]
2023. Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Analysis of Mental Health and Associated Disorders. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s300. DOI:https://doi.org/10.25251/skin.7.supp.300.